Oligonucleotide Synthesis Market Research Report: Trends Forecast Till 2028


Posted March 5, 2024 by delvens123

The global oligonucleotide synthesis market is projected to reach USD 14.1 billion by 2026 from USD 6.3 billion in 2021, at a CAGR of 17.6% during the forecast period.

 
Oligonucleotide Synthesis Market, by Product (Drug, Synthesized Oligos (Primer, Probe), Reagents), Type (Custom, Predesign), Application (Therapeutic (ASO, siRNA), Research (PCR), Diagnostic), End User (Hospital, Pharma, CROs) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America).
Oligonucleotide Synthesis Market Overview
The global oligonucleotide synthesis market is projected to reach USD 14.1 billion by 2026 from USD 6.3 billion in 2021, at a CAGR of 17.6% during the forecast period.
Increasing use of synthesized oligos in therapeutic applications, increasing government funding, and the growing focus on personalized medicine are the major factors that have supported long term expansion of Global Oligonucleotide Synthesis Market.
Get a Sample Copy of the Oligonucleotide Synthesis Market Research Report: https://www.delvens.com/get-free-sample/oligonucleotide-synthesis-market
Key Findings
Global Oligonucleotide Synthesis Market is segmented into product, application, end user and geography.
Product segment is segmented into oligonucleotide-based drugs, synthesized oligonucleotide, reagents and equipment.
Application segment is segmented into therapeutic applications, therapeutic applications by disease type, diagnostic application and research applications.
End user segment is segmented into hospitals, pharmaceuticals & biotechnology companies, diagnostic laboratories, contract research organizations and contact manufacturing organizations (CROS & COMS) and academic research institutes.
Geographically, Global Oligonucleotide Synthesis market is sub segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions
Oligonucleotide Synthesis Market Competitive Landscape
Key players
Danaher Corporation (US)
Thermo Fisher Scientific Inc. (US)
Merck KGaA (Germany)
LGC Limited (UK)
Maravai Life Sciences (US)
Agilent Technologies Inc. (US).
• The prominent players in the oligonucleotide therapeutics market are Biogen Inc. (US) and Sarepta Therapeutics, Inc. (US).
Inquire before you purchase to increase your business' revenue: https://www.delvens.com/Inquire-before-buying/oligonucleotide-synthesis-market
Reasons to Acquire in the Oligonucleotide Synthesis Market
• Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
• Gain authentic and granular data access for oligonucleotide synthesis market so as to understand the trends and the factors involved behind changing market situations
• Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
• In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns
Direct Purchase of Oligonucleotide Synthesis Market Report Research Report: https://www.delvens.com/checkout/oligonucleotide-synthesis-market
Frequently Asked Questions
What are the years considered to study Oligonucleotide Synthesis Market?
What is the compound annual growth rate (CAGR) of the Oligonucleotide Synthesis Market?
Which region holds the largest market share in Oligonucleotide Synthesis Market?
Which region is the fastest growing region in Oligonucleotide Synthesis Market?
Who are the major players in Oligonucleotide Synthesis Market?
Browse Related Reports:
Magnetic Resonance Imaging (MRI) Coils Market – Trends Forecast Till 2030
Magnetic Resonance Imaging (MRI) Coils Market by Type (Radiofrequency coil, Gradient coils), by Application (Body Oncology, Neuro and spine, Cardiovascular, Pediatric, Others), by End User (Hospitals and Clinics, Diagnostic Imaging Centers) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).
Diagnostic Imaging Services Market – Trends Forecast Till 2030
Diagnostic Imaging Services Market, By Procedure (Computed Tomography, MRI, and X-ray), By Application (Neurology, Oncology, and Cardiology), By Service Provider (Diagnostic Centres, Hospitals, Ambulatory Surgical Centers, and Others), and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact Us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-8638-5055
[email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Delvens
Phone 02086385055
Business Address UNIT NO. 2126, TOWER B,, 21ST FLOOR ALPHATHUM, SECTOR 90 NOIDA 201305, IN
Country United Kingdom
Categories Health , Industry , Reports
Last Updated March 5, 2024